Melanoma/Skin Cancer News

Reflectance confocal microscopy may increase consistent and accurate melanoma diagnoses independently of clinical and dermoscopic features, according to a study.

Clinical gene expression profiling may be able to better identify melanoma patients who can safely forgo sentinel lymph node biopsy compared with current recommended conventions, according to a study.

Precision oncology therapies requiring biomarker testing comprised 43% of all FDA oncology drug approvals between 1998 and 2022, study results published in Cancer Discovery showed.

Primary melanomas with incipient ulceration may be more aggressive than nonulcerated melanomas, thus warranting a higher-risk pathologic T stage, according to a study.

The Society for Immunotherapy of Cancer has issued an update to its melanoma clinical practice guideline.

Specialty training in dermatopathology correlated with a greater tendency to diagnose low risk melanomas as more severe, according to a study.

The FDA announced several regulatory actions.

President Joe Biden today announced his intention to appoint oncologist, researcher and educator, W. Kimryn Rathmell, MD, PhD, as director of the NCI.

Patients with metastatic basal cell carcinoma experiencing distant organ involvement have worse outcomes than patients with nodal involvement, according to a study.

The number of cancer surgeries, chemotherapy treatments and radiation treatments declined dramatically during the first months of the COVID-19 pandemic, study findings published in JAMA Oncology showed.